- Report
- October 2023
- 80 Pages
Turkey
From €3373EUR$3,500USD£2,901GBP
- Report
- February 2024
- 80 Pages
Finland
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 80 Pages
Canada
From €4577EUR$4,750USD£3,937GBP
- Report
- April 2023
- 80 Pages
Denmark
From €4577EUR$4,750USD£3,937GBP
- Report
- April 2023
- 80 Pages
Netherlands
From €4577EUR$4,750USD£3,937GBP
- Report
- April 2023
- 90 Pages
Australia
From €4577EUR$4,750USD£3,937GBP
- Report
- July 2022
- 85 Pages
Belgium
From €4577EUR$4,750USD£3,937GBP
- Report
- January 2022
- 111 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- January 2022
- 80 Pages
Norway
From €4577EUR$4,750USD£3,937GBP
- Report
- January 2022
- 80 Pages
Iceland
From €4577EUR$4,750USD£3,937GBP
- Report
- May 2023
- 220 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- February 2023
- 120 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- February 2023
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3132EUR$3,250USD£2,694GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3132EUR$3,250USD£2,694GBP
- Report
- January 2022
- 60 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- April 2020
- 75 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- April 2020
- 80 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- April 2020
- 75 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2020
- 142 Pages
Global
From €6022EUR$6,250USD£5,180GBP
The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient.
The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more